
Louise Burrell MD
@LouiseBurrell3
Followers
478
Following
2K
Media
35
Statuses
458
Physician-scientist; Professor of Medicine, University of Melbourne; Long time cardiovascular 🫀 / ACE2 researcher; Opinions my own.
Melbourne, Victoria
Joined March 2013
Congratulations to the brilliant @drThalysSR for an excellent oral presentation #CSANZ2023! You’ve been a privilege to supervise and mentor @LouiseBurrell3 @kaznegishi @thecsanz @Austin_Health @drchrisyu @HeartLungCirc @dralexcmurphy @DrJRamchand @INRanadive
0
1
20
This might be the best thing I’ve ever seen - @NirUrielMD running a spin class, while giving a lecture on heart failure. One for the books for sure. @AbbottCardio @AlbertHicksMD @rcogswell_umn @DRJoycewald @davenport_clay @UlrichJordeMD @gtsayer @DrJennHaythe
73
276
2K
I am honoured to receive the @UniMelbMDHS Dean’s award for excellence. So many to thank but most importantly @drmatiasyudi @DrAnoop_Koshy @LouiseBurrell3 @Drroxmehran and the @Austin_Health community for making this dream a reality 💕#smartbreast #wic @WomenAs1 @VicWIC_au
4
2
34
IBAS AGM- shout out to Bill Noonan , the previous CHair of tve Board- thank you @IBAS_Austin @Austin_Health
0
0
4
Ironically, our paper about real-world effects of COVID-19 medications is out today. Early in the roll-out of CMDUs there was relative equipoise and marked variation in treatment, enabling a robust comparison of sotrovimab and molnupiravir. https://t.co/gNqtTxXAiL
bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients infected with...
3
20
42
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
bmj.com
Objective To determine whether disrupting the renin angiotensin system with angiotensin receptor blockers will improve clinical outcomes in people with covid-19. Design CLARITY was a pragmatic,...
0
0
2
Very bad decision by the Fed Gov. Australian organisation offering independent advice on medicines is axed after funding is cut
bmj.com
NPS MedicineWise, an Australian organisation offering independent and evidence based information on medicines, is to close at the end of 2022 after the federal government decided to cut its funding....
0
0
1
Without discovery research there are no medical breakthroughs, yet today we see a significant decline in funding for discovery researchers. There is no translation or advancement in knowledge without the discovery pipeline. https://t.co/9RgzoNvMwa
@OzCvA @gemtreee @HRIAust
cosmosmagazine.com
Heart disease remains our biggest killer – does the research funding it receives match its overall cost to the health system?
1
17
52
CLARITY on a clinically controversial question. Wonderful collaboration successfully completed during pandemic disruption. Publ BMJ wk Nov9 @vjha126 @SradhaKotwal @abhinavbassi @carinnahockham @TrialsCentre @GeorgeInstIN @LouiseBurrell3 #CarolPollock #ManyOthers #PatientPartners
1
3
6
Security closed at t1 Mel airport- no reason given. But no flights departing.@Qantas
1
0
1
Breaking News!📢 According to several sources, the Japanese government is making arrangements to facilitate entry into Japan. Travelers will be exempt from tourist visas if they receive 3rd vac or negative certificate. Prime Minister will make a final decision this week. @ISHBP
2
12
30
Queen Elizabeth II, Britain’s longest-reigning monarch, dies aged 96
theguardian.com
Death draws to a close Britain’s second Elizabethan era and heralds the reign of her son, King Charles III
0
0
2
Really interesting results on the time you take your AHT meds on outcomes. TIME study- The Treatment in Morning versus Evening study. Thanks to Tom MacDonald for the study and discussion by @LabTouyz ESC Congress 2022 Barcelona | HOT LINE SESSION 1 https://t.co/QSJG1OlWdp ][p0
esc365.escardio.org
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
0
0
4
Great discussion by Dr Wang on publishing processes. A must listen to for ECRs. ESC Congress 2022 Barcelona | Highlights from circulation: arrhythmia and electrophysiology and new initiatives
esc365.escardio.org
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
0
0
1
Excellent session to kick off ESC- thank you ! ESC Congress 2022 Barcelona | The next frontiers in innovative therapies
esc365.escardio.org
ESC 365 is the cardiology knowledge hub where you’ll find resources, whenever you want them from congresses, webinars, courses, publications and podcast.
0
0
0
Excellent presentation by Dr Alex Murphy in the Ralph Reader Prize Session @ CSANZ @dralexcmurphy @DrAnoop_Koshy @Austin_Health @UniMelbMDHS @DrJRamchand
0
1
12
I am so invigorated and inspired by the amazing and emerging talent embedded across the #csanz2022 program @thecsanz with fresh clinically relevant discoveries that will benefit our patients. World-class meeting @ProfSNicholls @clara_chow @OzCvA @MonashHeart @CSHeartResearch
1
4
45
0
2
8